SE0202702L - Immunotest för specifik bestämning av SCCA isoformer - Google Patents

Immunotest för specifik bestämning av SCCA isoformer

Info

Publication number
SE0202702L
SE0202702L SE0202702A SE0202702A SE0202702L SE 0202702 L SE0202702 L SE 0202702L SE 0202702 A SE0202702 A SE 0202702A SE 0202702 A SE0202702 A SE 0202702A SE 0202702 L SE0202702 L SE 0202702L
Authority
SE
Sweden
Prior art keywords
immunoassay
scca
specific determination
well
isoforms
Prior art date
Application number
SE0202702A
Other languages
English (en)
Swedish (sv)
Other versions
SE0202702D0 (sv
Inventor
Eva Roejer
Olle Nilsson
Original Assignee
Canag Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canag Diagnostics Ab filed Critical Canag Diagnostics Ab
Priority to SE0202702A priority Critical patent/SE0202702L/xx
Publication of SE0202702D0 publication Critical patent/SE0202702D0/xx
Priority to PCT/SE2003/001332 priority patent/WO2004024767A1/fr
Priority to AU2003256194A priority patent/AU2003256194B9/en
Priority to AT03795518T priority patent/ATE532796T1/de
Priority to DK03795518.4T priority patent/DK1539817T3/da
Priority to EP03795518A priority patent/EP1539817B1/fr
Priority to JP2004535315A priority patent/JP2006516114A/ja
Priority to CA2498524A priority patent/CA2498524C/fr
Priority to KR1020057004488A priority patent/KR20050071493A/ko
Priority to CNA038235161A priority patent/CN1684981A/zh
Priority to RU2005110410/13A priority patent/RU2005110410A/ru
Priority to ES03795518T priority patent/ES2376167T3/es
Priority to BR0314207-8A priority patent/BR0314207A/pt
Priority to US10/652,705 priority patent/US20040176577A1/en
Publication of SE0202702L publication Critical patent/SE0202702L/xx
Priority to HK06100144.9A priority patent/HK1080091A1/zh
Priority to US11/765,725 priority patent/US20080057520A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE0202702A 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer SE0202702L (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE0202702A SE0202702L (sv) 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer
BR0314207-8A BR0314207A (pt) 2002-09-10 2003-08-27 Imunoensaios para a determinação especìfica de isoformas de scca
JP2004535315A JP2006516114A (ja) 2002-09-10 2003-08-27 Ｓｃｃａアイソフォームの特異的測定のためのイムノアッセー
KR1020057004488A KR20050071493A (ko) 2002-09-10 2003-08-27 Ｓｃｃａ 동소체의 특이적 결정을 위한 면역검사
AT03795518T ATE532796T1 (de) 2002-09-10 2003-08-27 Immunassays zur spezifischen bestimmung von scca- isoformen
DK03795518.4T DK1539817T3 (da) 2002-09-10 2003-08-27 Immunoassays til specifik bestemmelse af SCCA-isoformer
EP03795518A EP1539817B1 (fr) 2002-09-10 2003-08-27 Immuno-essais servant a effectuer la determination specifique d'isoformes de scca
PCT/SE2003/001332 WO2004024767A1 (fr) 2002-09-10 2003-08-27 Immuno-essais servant a effectuer la determination specifique d'isoformes de scca
CA2498524A CA2498524C (fr) 2002-09-10 2003-08-27 Immuno-essais servant a effectuer la determination specifique d'isoformes de scca
AU2003256194A AU2003256194B9 (en) 2002-09-10 2003-08-27 Immunoassays for specific determination of SCCA isoforms
CNA038235161A CN1684981A (zh) 2002-09-10 2003-08-27 用于单独测定scca同形异构体的免疫测定法
RU2005110410/13A RU2005110410A (ru) 2002-09-10 2003-08-27 Иммуноанализы для специфического определения изоформ scca
ES03795518T ES2376167T3 (es) 2002-09-10 2003-08-27 Inmunoensayos para la determinación espec�?fica de isoformas de scca.
US10/652,705 US20040176577A1 (en) 2002-09-10 2003-08-29 Immunoassays for specific determination of SCCA isoforms
HK06100144.9A HK1080091A1 (zh) 2002-09-10 2006-01-04 用於單獨測定scca同形異構體的免疫測定法
US11/765,725 US20080057520A1 (en) 2002-09-10 2007-06-20 Immunoassays for specific determination of scca isoforms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202702A SE0202702L (sv) 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer

Publications (2)

Publication Number Publication Date
SE0202702D0 SE0202702D0 (sv) 2002-09-10
SE0202702L true SE0202702L (sv) 2004-05-10

Family

ID=20288971

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202702A SE0202702L (sv) 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer

Country Status (14)

Country Link
EP (1) EP1539817B1 (fr)
JP (1) JP2006516114A (fr)
KR (1) KR20050071493A (fr)
CN (1) CN1684981A (fr)
AT (1) ATE532796T1 (fr)
AU (1) AU2003256194B9 (fr)
BR (1) BR0314207A (fr)
CA (1) CA2498524C (fr)
DK (1) DK1539817T3 (fr)
ES (1) ES2376167T3 (fr)
HK (1) HK1080091A1 (fr)
RU (1) RU2005110410A (fr)
SE (1) SE0202702L (fr)
WO (1) WO2004024767A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5750645B2 (ja) * 2009-12-07 2015-07-22 株式会社シノテスト アレルギー疾患の検査方法
JP5750646B2 (ja) * 2009-12-07 2015-07-22 株式会社シノテスト Ｓｃｃａ２濃度測定によるアレルギー疾患の検査方法
CN102435740A (zh) * 2011-08-31 2012-05-02 内蒙古科慧生物科技有限责任公司 鳞状细胞癌抗原(scc)定量测定试剂盒及其检测方法
WO2013118073A1 (fr) * 2012-02-07 2013-08-15 Bioalternatives Sas Serpinb4, comme marqueur destiné à une évaluation précoce de la réponse à des thérapies anti-egfr par un procédé non invasif
CN106318912B (zh) * 2016-08-23 2019-01-25 广州瑞博奥生物科技有限公司 杂交瘤细胞株scca1及其分泌的单克隆抗体和应用
CN109212190A (zh) * 2018-09-26 2019-01-15 郑州安图生物工程股份有限公司 一种检测鳞状细胞癌抗原的试剂盒
CN113125723A (zh) * 2019-12-31 2021-07-16 瑞博奥(广州)生物科技股份有限公司 一种检测男性恶性肿瘤标志物的检测芯片及其制备方法和应用
CN112280746A (zh) * 2020-10-29 2021-01-29 杭州华葵金配生物科技有限公司 一种细胞癌抗原杂交瘤细胞株及其单克隆抗体的应用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4668889A (en) * 1988-11-23 1990-06-12 The Administrators Of The Tulane Eductional Fund Monoclonal antibodies specific for tumor antigens
AU5830400A (en) * 1999-06-30 2001-01-22 Arto Orpana Diagnostic method for squamous cell carcinoma
SE521652C2 (sv) * 2001-03-15 2003-11-25 Canag Diagnostics Ab En skivepitelcellcancerrelaterad fusionsgen och motsvarande fusionsprotein

Also Published As

Publication number Publication date
RU2005110410A (ru) 2005-11-20
AU2003256194B9 (en) 2010-10-21
ATE532796T1 (de) 2011-11-15
CA2498524A1 (fr) 2004-03-25
EP1539817A1 (fr) 2005-06-15
CN1684981A (zh) 2005-10-19
SE0202702D0 (sv) 2002-09-10
AU2003256194A1 (en) 2004-04-30
DK1539817T3 (da) 2012-02-06
ES2376167T3 (es) 2012-03-09
CA2498524C (fr) 2013-08-13
HK1080091A1 (zh) 2006-04-21
BR0314207A (pt) 2005-07-26
AU2003256194B2 (en) 2010-10-07
KR20050071493A (ko) 2005-07-07
JP2006516114A (ja) 2006-06-22
WO2004024767A1 (fr) 2004-03-25
EP1539817B1 (fr) 2011-11-09

Similar Documents

Publication Publication Date Title
HK1080091A1 (zh) 用於單獨測定scca同形異構體的免疫測定法
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ATE361935T1 (de) Monoklonale antikörper spezifisch für die extrazelluläre domäne des prostata-spezifischen membranantigens
TW200801202A (en) Alpha-enolase specific antibody and method of use
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
BRPI0410261B8 (pt) anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
WO2005120166A3 (fr) Anticorps pour apoptose selective de cellules
PH12020551371A1 (en) Assays to detect neurodegeneration
TW200740842A (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
BRPI0712273A8 (pt) anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit
DE69716305D1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
MX2022013738A (es) Ensayo de anticuerpos neutralizantes para proteinas terapeuticas.
BRPI0208021B8 (pt) genes de antígeno ii de carcinoma de células escamosas rearranjados
DE59109139D1 (de) Immunologischer Nachweis von Metolachlor
WO2006060188A3 (fr) Dosages immunologiques d'anticorps monoclonal anti-tenascine et kits diagnostiques
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
WO2008099419A3 (fr) Autoanticorps pour des antigènes protéiques utilisés en tant que marqueurs du cancer du complexe gingivo-buccal
SE0100595D0 (sv) Immunological detection of prostate diseases and prostatic-related diseases
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
WO2018226098A3 (fr) Procédés de typage des troubles neurologiques et du cancer, et dispositifs associés
IT1317355B1 (it) Anticorpi policlonali.
GB0501564D0 (en) Test for prion disease
ATE532074T1 (de) Auf multi-immunoaffinität basierende indentifizierung von antigenen
WO2020010304A3 (fr) Anticorps anti-bcl-2 et dosage immunologique pour le diagnostic du cancer